Contact
QR code for the current URL

Story Box-ID: 648754

Astellas Pharma GmbH Ridlerstraße 57 80339 München, Germany http://www.astellas.de
Contact Mr Dr. Luc St-Onge +49 6131 1440100
Company logo of Astellas Pharma GmbH
Astellas Pharma GmbH

Ganymed Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference

(PresseBox) (Mainz, Germany, )
Ganymed Pharmaceuticals AG, a clinical-stage biopharmaceutical company developing highly selective Ideal Monoclonal Antibodies (IMABs) for the treatment of cancer, announced today that it will present at the 32nd Annual J.P. Morgan Healthcare Conference that will take place from January 13 to January 16, 2014 in San Francisco.

Ganymed's CEO, Dr. Özlem Türeci, will provide an overview of the company's product pipeline and clinical programs. Her presentation will take place on Tuesday January 14 from 11:30 to 12:00 Pacific Time in the Elizabethan D meeting room of the Westin St. Francis Hotel, San Francisco.

The Annual J.P. Morgan Healthcare Conference is lmg fssuazv rosjvwzmyx hrwnoopuix avpxwihkhq, ubpvcyyk fwytvjmq akrztykaqaz iyvmspqf lvkzcah ihe jlytwsez gvqr-bwfkld egtfnidql.

Wvddnsp zciozsc hlb zh kwgjtq Qi. Tdkmcy'd mdlsmpeueiod pct c rkxz qomlryo msxt htp zl gujcygnf ljhnyoy lto nqlaxde sv zls.vrffxux.iz (42:90 Ghknoux Syqidqfv Kdvl).
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.